← All candidates
One insider buy in the last year — $5.0K in all.
19 filings on record.
OSURORASURE TECHNOLOGIES INC
NasdaqGS · Healthcare · $240.01M
$3.48
+0.58% today
One insider buy in the last year — $5.0K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$240.01M
Float
60.9M
88% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
2.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Gagliano Nancy J
Bought $5.0K on Nov 28 — 2,100 sh @ $2.37, held direct, 1.3% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
14 more transactions on Pro →Context
Wall St
$4.75 avg target
+36.5% vs today · 2 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26−$0.24 act−$0.07
Q4 '25−$0.19 act−$0.04
Q3 '25−$0.13 act+$0.02
Q2 '25−$0.19 act−$0.04
The file stays open
19 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice